Clinical Summarization & Chart Review
U

Ultralight

Ultralight, renamed from Vibrant Practice in April 2026 (the company is still Vibrant Practice, Inc., doing business as Ultralight), is an AI-native electronic health record and practice platform for functional, integrative and longevity medicine, concierge and cash-pay practices, and women's health and hormone clinics. It replaces the practice's system of record: charting, labs, prescribing, telehealth, scheduling, billing, automated follow-ups, and a patient app for messaging, documents, appointments and connected devices.

The AI work is documentation and synthesis. An AI scribe drafts visit notes and after-visit summaries; specialty lab and multi-omics results are parsed and trended beside data from Dexcom, FreeStyle Libre, Oura, Apple Health and Android Health Connect; and Copilot answers questions about a patient's chart and trends. The platform also offers evidence-based insights, predictive prompts on what a patient needs next, and personalized care plans and protocols (supplements, IVs, peptides, nutrition and lifestyle) drawn from a proprietary knowledge base the company says functional medicine experts review, or from the practice's own. No model, model provider or evaluation is published.

Pricing is published: per seat on the Core plan ($525 prescribing, $300 non-prescribing, $50 a month for unlimited admin seats) with a $995 implementation fee, special pricing for new practices and custom pricing for larger groups. The company was founded by Sunita Mohanty and Pedro Tabio, says 75 clinics are live, and was reported in April 2026 to have raised $9.3 million in a round led by The General Partnership. Because the product holds the whole record, ask for the business associate agreement, the export format on exit and any independent security assessment before migrating.

AI Health Index verifiedSeptember 29, 2026
Compare Ultralight with other vendors
Founded
2024
Headquarters
Sacramento, CA, US
Categories
clinical-summarization
Indexed Products
Ultralight AI-native EHR and practice platform, AI scribe and Copilot, Lab, diagnostics and wearable trends, Personalized care plans and protocols, Ultralight patient app
Buyer Segments
Functional and integrative medicine practices, Longevity and optimization clinics, Concierge, cash-pay and direct primary care practices, Women's health and hormone clinics, Multi-site practices (Enterprise plan)
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
BB on AI CentralityThe model is the engine of a core module. The platform carries other value, but this capability does not exist without it.
Vendor Published

The models run core modules of a full record system. Ultralight is an EHR and practice platform (charting, labs, prescribing, telehealth, billing, scheduling and a patient app), and its AI scribe, lab and wearable synthesis, and Copilot, which answers questions about a patient's chart and device trends, would not exist without models. Scheduling, billing, messaging and the record itself would still stand without them, which is why this is not an A. Ask which modules a practice can run with the AI switched off.

CC on Autonomy and Oversight ModelAutonomy is claimed and oversight is asserted without a mechanism. Human in the loop appears as a phrase rather than a described control.
Vendor Published

Control is asserted without a described mechanism. The platform page says charting, visit prep and data synthesis happen automatically while clinicians stay in control of final decisions, and the company's own AI guide tells clinicians to ask any vendor where the line sits between draft and wait and execute automatically.

Ultralight does not publish that line for its own product: nothing says whether AI-drafted notes, care plans or follow-ups need sign-off before they reach the chart or the patient app, and no confidence signal or abstention behavior is described. Ask exactly which outputs wait for approval.

CC on Model and Technology TransparencyThe architecture is described in general terms with nothing identified. Proprietary is asserted rather than explained.
Vendor Published

The functions are described and nothing producing them is identified. The company describes an AI scribe, specialty lab parsing, trend synthesis across labs and wearables, and Copilot, and says plans draw on a proprietary knowledge base reviewed by functional medicine experts. No model or model family, training or fine-tuning data, version or update practice is published. Ask which models produce notes, insights and care plans, and how practices learn when they change.

CC on Model Supply Chain DisclosureThe architecture is described and no model provider is named. Naming a hosting provider alone does not lift a record out of this band. Record the host in the note, because it matters for residency and breach scope, and grade on the model layer, which is the question this axis is named for.
Vendor Published

The architecture is described and no model provider is named. The AI features read the chart, labs and device data inside the platform, and the privacy policies name Google Analytics and reserve disclosure to unnamed vendors and service providers. No hosting provider, model provider or subprocessor list is published, and nothing states the retention or training terms that apply once clinical content reaches one. Ask for the subprocessor list, including any model provider and scribe vendor, and the terms that bind them.

CC on Clinical and Operational EvidenceNamed customers, or vendor reported percentages with no method, denominator or reference standard. Scale of use is recorded here and is not treated as evidence of benefit.
Vendor Published

Named clinics and vendor figures with no method. Four clinics are quoted on the home page (D5 Health, Farm to Functional, Kuros Medical, Living Proof Medicine), and the company says 75 clinics are live. Its results claims, 10 to 15 hours reclaimed weekly per clinician, a 25 percent increase in patient capacity and 10 percent higher margins, and one clinician's 10 hours a week cut to 30 minutes, carry no method or denominator. Ask a named clinic for its before and after measures.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

A retention schedule is published for the patient app and nothing about what reaches a model. The patient app privacy policy (18 Apr 2025) says the company processes information on behalf of the practice, hosts in the United States, keeps account data for 30 days after a verified deletion request, communications and security logs for six years and usage data for up to 12 months, and may use de-identified or aggregated data for any lawful purpose.

Nothing says whether clinical content reaches an outside model provider or trains any model. The App Store listing declares that the developer does not collect any data from the app, which the company's own policy contradicts. Ask whether patient data trains any model, which provider processes it, and for the terms that govern provider-controlled records.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here. A vendor whose product does not process protected health information grades here too when it says so plainly and explains the scope, with a service privacy document behind it: stating a position a buyer can rely on is the posture this axis grades, and the band above is closed to it because there is no agreement to publish.
Vendor Published

Agreement status is stated and a service privacy document stands behind it. The terms of use (9 Jun 2025) permit production access only after a master subscription agreement and, where applicable, a business associate agreement are signed, and the patient app privacy policy describes the company as processing information on behalf of the practice. The agreement itself is not published, and the clinical app privacy policy is a short website notice from July 2024. Many practices in this market are cash pay, so ask when the company treats the agreement as applicable, and for the agreement and its subcontractor terms.

DD on Security Certifications and Trust CenterControls are asserted with nothing independent behind them, or nothing is published. Read the note before concluding anything: this is the grade most often corrected on a second pass, because assurance material frequently sits on a parent domain or inside an old announcement rather than on the product pages.
Vendor Published

Nothing independent is published. The company's security page is published with a generic heading and no security content, the privacy policies promise reasonable safeguards, and no attestation, penetration test, trust center or report request path appears on the pages read or in search. For a product that holds a practice's entire record, prescribing and messaging, ask for any independent assessment, the backup and recovery arrangements, and the breach process.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalized for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance.
Vendor Published

No device claim is made and no regulatory position is published, beside functions that press on one. FDA's 510(k) database lists no clearance for the company. The platform offers evidence-based insights to guide recommendations, predictive insights on what each patient needs next, continuously updated therapy guidance, and personalized care plans covering supplements, IVs, peptides, nutrition and lifestyle that are shared with the patient. Ask for the company's regulatory analysis of the therapy guidance and predictive insights, and whether a clinician approves each plan before a patient sees it.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

Expert review is claimed without an evaluation. Treatment plans and protocols draw on a proprietary knowledge base the company says is reviewed by functional medicine experts, and practices can add their own; advisors with functional medicine credentials are named, and the company's AI guide warns that general models were trained on conventional medicine.

No evaluation of the scribe, the synthesis or the care plan output is published, by patient group or otherwise, and nothing says what sources the knowledge base draws on or how it is updated. Ask for the knowledge base's sources and review process, and for any accuracy check on generated care plans.

DD on AI Liability and RecourseNothing published on what happens when the system is wrong.
Vendor Published

Nothing published says what happens when the output is wrong. No error rate, accuracy figure for the scribe or the lab synthesis, warranty, indemnity or remediation commitment is published, and no mechanism for challenging an output (citations to sources, review before commit) is described for the product. The patient app privacy policy lists audit trails only as a record type it retains for six years.

The sandbox is provided as is, and production use requires a master subscription agreement that is not published. Ask what the agreement says about errors in AI-drafted notes and care plans, and how a clinician traces an insight to its source.

Integration and Deployment
BB on EHR and Interoperability DepthNamed systems with read access or one directional writing, or standards support with named deployments behind it.
Vendor Published

Named device connections read into the record; lab, exchange and export routes are not named. The company's wearable integration guide documents direct connections to Dexcom, FreeStyle Libre and Oura, and Apple Health and Android Health Connect for other devices, with Whoop in progress; the data appears in the chart's trends beside labs.

Specialty labs and multi-omics results are described as auto-ingested and trended, with no laboratory named, and migration from a previous EHR is offered as an AI-driven service. Because this is the system of record, ask which labs interface directly, whether e-prescribing and exchange connections exist, and in what format a practice can export its full record on exit.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

A single hosted service with the country stated and nothing more. Both privacy policies say the services are hosted in the United States, that data may be moved to other countries for storage and processing, and that the services are intended for users in the United States. No cloud provider, region, tenant isolation or customer hosted option is published. The patient app runs on iPhone and Android. Ask for the hosting provider and region, which processing leaves the United States, and what the app keeps on the device.

Commercial
BB on Commercial TransparencyA price or a pricing basis is published without full tiers, so a buyer can size the cost before making contact.
Vendor Published

Tiers and seat prices are published, and starting still goes through a form. The Core plan for practices above 50 patients is priced per seat: $525 for a prescribing clinician, $300 non-prescribing and $50 a month for unlimited admin seats, with patient app and platform features included; implementation is $995 per practice, and data migration is custom priced. Practices under 50 patients apply for special pricing, and multi-site or 1,000+ patient practices get custom pricing. The billing period for clinician seats is not stated, and every Get started link opens an intake form. Ask for the seat period, contract term and migration estimate.

CC on Setting and Specialty CoverageCoverage is claimed broadly without specifics, or stated clearly with nothing validating it yet.
Vendor Published

Coverage is stated clearly with nothing validating it. The product is built for functional, integrative and longevity medicine, concierge and cash-pay practices, and women's health and hormone clinics, each described on the home page, and the company says 75 clinics are live. No evaluation of the AI output in any of these settings is published, and the specialty knowledge base is described without its sources. Ask which specialties the knowledge base covers and how its protocols were reviewed.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
$300 per non-prescribing clinician seat, $525 per prescribing seat (Core plan; billing period not stated)
$300 baseline
Per seat, published: prescribing and non-prescribing clinician seats, $50 a month for unlimited admin seats, patient app included. Special pricing for practices under 50 patients; custom pricing for multi-site practices or above 1,000 patients. The terms of use require a signed master subscription agreement and, where applicable, a business associate agreement before production use; the agreement is not published. $995 per practice, including support and training. Data migration from an existing EHR is custom priced by record volume and complexity. Vendor Published

The Core plan is priced per seat and published: $525 for a prescribing clinician, $300 for a non-prescribing clinician and $50 a month for unlimited admin seats, with platform features and the patient app included. Implementation is $995 per practice. Startup practices under 50 patients apply for special pricing, and multi-site practices or those above 1,000 patients get custom pricing with optional white-labeled apps and custom reports.

Three things to settle before signing. The billing period for clinician seats, which the page does not state. The migration estimate, since data migration is priced separately by record volume and complexity. And the exit terms, because this product replaces the system of record: ask in what format the full record, including messages, documents, lab history and care plans, comes back if you leave, and what that costs.